| scholarly article | Q13442814 |
| P2093 | author name string | Jada Lewis | |
| Todd E Golde | |||
| David R Borchelt | |||
| Guilian Xu | |||
| Susan E Fromholt | |||
| Paramita Chakrabarty | |||
| Jin Koh | |||
| Fanchao Zhu | |||
| Yona Levites | |||
| Xuefei Liu | |||
| Michael C Pace | |||
| P2860 | cites work | Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins | Q39155261 |
| Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases | Q39440179 | ||
| Brain amyloid and Alzheimer disease | Q39644209 | ||
| IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior. | Q42174144 | ||
| A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease | Q43680495 | ||
| Comparison of label-free methods for quantifying human proteins by shotgun proteomics. | Q46568113 | ||
| Practical considerations for choosing a mouse model of Alzheimer's disease | Q47135235 | ||
| ApoE4 Accelerates Early Seeding of Amyloid Pathology | Q47319238 | ||
| Neuropathology of cognitively normal elderly | Q48125911 | ||
| Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice. | Q48711626 | ||
| Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. | Q48795523 | ||
| Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. | Q48889458 | ||
| Soluble amyloid beta-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls. | Q52021816 | ||
| The PRIDE database and related tools and resources in 2019: improving support for quantification data | Q58611633 | ||
| Changes in proteome solubility indicate widespread proteostatic disruption in mouse models of neurodegenerative disease. | Q64949212 | ||
| Alzheimer's disease | Q88910788 | ||
| Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease | Q21144713 | ||
| Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer's disease brain | Q24302165 | ||
| PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees | Q24595315 | ||
| The PANTHER database of protein families, subfamilies, functions and pathways | Q24795605 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Self-propagation of pathogenic protein aggregates in neurodegenerative diseases | Q26996441 | ||
| Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
| Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase | Q28188098 | ||
| Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease | Q28504767 | ||
| The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease | Q30705340 | ||
| Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. | Q31840691 | ||
| SAINT: probabilistic scoring of affinity purification-mass spectrometry data | Q33763365 | ||
| Abeta42 is essential for parenchymal and vascular amyloid deposition in mice | Q34374693 | ||
| National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease | Q34635272 | ||
| Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition | Q34878224 | ||
| National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach | Q35706615 | ||
| Murine Aβ over-production produces diffuse and compact Alzheimer-type amyloid deposits | Q36278396 | ||
| Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease | Q36784564 | ||
| Normal cognition in transgenic BRI2-Aβ mice | Q36858817 | ||
| Cytosolic proteins lose solubility as amyloid deposits in a transgenic mouse model of Alzheimer-type amyloidosis | Q36950666 | ||
| Vulnerability of newly synthesized proteins to proteostasis stress | Q36970419 | ||
| Reversible pathologic and cognitive phenotypes in an inducible model of Alzheimer-amyloidosis | Q37013605 | ||
| Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship | Q37218110 | ||
| IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice | Q37232963 | ||
| Rapid label-free identification of estrogen-induced differential protein expression in vivo from mouse brain and uterine tissue. | Q37407599 | ||
| Clearance of extracellular misfolded proteins in systemic amyloidosis: experience with transthyretin | Q38028212 | ||
| Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease. | Q38297925 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 43 | |
| P577 | publication date | 2020-04-06 | |
| P1433 | published in | Acta Neuropathologica Communications | Q27724912 |
| P1476 | title | Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis | |
| P478 | volume | 8 |
Search more.